BioNxt Solutions (OTCMKTS:BNXTF) Shares Down 6.7% – Time to Sell?

BioNxt Solutions Inc. (OTCMKTS:BNXTFGet Free Report)’s share price traded down 6.7% during mid-day trading on Friday . The company traded as low as $0.2141 and last traded at $0.2430. 1,578 shares traded hands during trading, an increase of 36% from the average session volume of 1,160 shares. The stock had previously closed at $0.2605.

BioNxt Solutions Price Performance

The firm has a market capitalization of $33.07 million, a price-to-earnings ratio of -4.86 and a beta of 0.75. The business’s fifty day simple moving average is $0.24 and its 200 day simple moving average is $0.30.

BioNxt Solutions (OTCMKTS:BNXTFGet Free Report) last issued its earnings results on Friday, August 28th. The company reported ($0.01) EPS for the quarter.

About BioNxt Solutions

(Get Free Report)

BioNxt Solutions Inc is a biotechnology company focused on developing pharmaceutical and drug-delivery technologies. Its work centers on alternative dosage forms designed to improve the administration, absorption, and convenience of medicines, including oral dissolvable and sublingual films, transdermal systems, and other novel delivery platforms.

The company’s development activities have included pharmaceutical products and delivery systems targeting areas such as neurological disorders and other medical conditions.

Read More

Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.